BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19167883)

  • 21. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase.
    Charvat TT; Lee DJ; Robinson WE; Chamberlin AR
    Bioorg Med Chem; 2006 Jul; 14(13):4552-67. PubMed ID: 16524737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors.
    Aiello F; Brizzi A; Garofalo A; Grande F; Ragno G; Dayam R; Neamati N
    Bioorg Med Chem; 2004 Aug; 12(16):4459-66. PubMed ID: 15265496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors.
    Nagasawa JY; Song J; Chen H; Kim HW; Blazel J; Ouk S; Groschel B; Borges V; Ong V; Yeh LT; Girardet JL; Vernier JM; Raney AK; Pinkerton AB
    Bioorg Med Chem Lett; 2011 Jan; 21(2):760-3. PubMed ID: 21185178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
    Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tricyclic HIV integrase inhibitors: potent and orally bioavailable C5-aza analogs.
    Jin H; Wright M; Pastor R; Mish M; Metobo S; Jabri S; Lansdown R; Cai R; Pyun P; Tsiang M; Chen X; Kim CU
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1388-91. PubMed ID: 18207398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Vince R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
    Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N
    ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.
    Wai JS; Kim B; Fisher TE; Zhuang L; Embrey MW; Williams PD; Staas DD; Culberson C; Lyle TA; Vacca JP; Hazuda DJ; Felock PJ; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Mallai R; Young SD
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5595-9. PubMed ID: 17822898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
    Li X; Vince R
    Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.
    Boros EE; Edwards CE; Foster SA; Fuji M; Fujiwara T; Garvey EP; Golden PL; Hazen RJ; Jeffrey JL; Johns BA; Kawasuji T; Kiyama R; Koble CS; Kurose N; Miller WH; Mote AL; Murai H; Sato A; Thompson JB; Woodward MC; Yoshinaga T
    J Med Chem; 2009 May; 52(9):2754-61. PubMed ID: 19374386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermolecular interactions in the crystal structures of potential HIV-1 integrase inhibitors.
    Majerz-Maniecka K; Musiol R; Nitek W; Oleksyn BJ; Mouscadet JF; Le Bret M; Polanski J
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1005-9. PubMed ID: 16289813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity.
    Bénard C; Zouhiri F; Normand-Bayle M; Danet M; Desmaële D; Leh H; Mouscadet JF; Mbemba G; Thomas CM; Bonnenfant S; Le Bret M; d'Angelo J
    Bioorg Med Chem Lett; 2004 May; 14(10):2473-6. PubMed ID: 15109635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of 5-fluoroquinolone-3-carboxylic acids as potential HIV-1 integrase inhibitors.
    He QQ; Zhang X; Yang LM; Zheng YT; Chen F
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):671-6. PubMed ID: 22468749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase--discovery of a new polyhydroxylated antiviral agent.
    Maurin C; Lion C; Bailly F; Touati N; Vezin H; Mbemba G; Mouscadet JF; Debyser Z; Witvrouw M; Cotelle P
    Bioorg Med Chem; 2010 Jul; 18(14):5194-201. PubMed ID: 20541944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of novel tricyclic HIV-1 integrase inhibitors by modification of its pyridine ring.
    Metobo SE; Jin H; Tsiang M; Kim CU
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3985-8. PubMed ID: 16723226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
    Sriram D; Yogeeswari P; Senchani G; Banerjee D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2372-5. PubMed ID: 17376679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
    Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and SAR studies of novel and highly active tri-cyclic HIV integrase inhibitors.
    Jin H; Cai RZ; Schacherer L; Jabri S; Tsiang M; Fardis M; Chen X; Chen JM; Kim CU
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3989-92. PubMed ID: 16723225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analogues of the styrylquinoline and styrylquinazoline HIV-1 integrase inhibitors: design and synthetic problems.
    Polański J; Niedbała H; Musioł R; Tabak D; Podeszwa B; Gieleciak R; Bak A; Pałka A; Magdziarz T
    Acta Pol Pharm; 2004 Dec; 61 Suppl():3-4. PubMed ID: 15909921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors.
    Patel M; Cianci C; Allard CW; Parker DD; Simmermacher J; Jenkins S; Mcauliffe B; Minassian B; Discotto L; Krystal M; Meanwell NA; Naidu BN
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127516. PubMed ID: 32860982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.